The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit

Ulf Soppa1, Julian Schumacher2, Victoria Florencio Ortiz3

  • 1Institute of Pharmacology and Toxicology; Medical Faculty; RWTH Aachen University; Aachen, Germany; Instituto de Neurociencias; Consejo Superior de Investigaciones Cientificas (CSIC) and Universidad Miguel Hernandez; Alicante, Spain.

Insights

Overexpression of DYRK1A kinase blocks neuronal precursor proliferation and promotes differentiation, potentially explaining brain abnormalities in Down syndrome.

Area of Science:

  • Neurobiology
  • Cell Biology
  • Developmental Neuroscience

Background:

  • Maintaining the balance between neuronal precursor proliferation and differentiation is crucial for proper brain development.
  • DYRK1A (dual specificity tyrosine-phosphorylation-regulated kinase 1A) is implicated in Down syndrome-associated brain abnormalities and may regulate the cell cycle.

Purpose of the Study:

  • To investigate the mechanisms by which DYRK1A influences cell cycle regulation and neuronal differentiation.
  • To elucidate DYRK1A's role in neurogenesis and its potential contribution to Down syndrome.

Main Methods:

  • Utilized a human neuroblastoma cell model (SH-SY5Y), primary mouse neurons, and embryonic mouse brain.
  • Investigated the effects of DYRK1A overexpression and kinase inhibition on cell proliferation, cell cycle phase, and protein stability of cell cycle regulators.

Main Results:

  • DYRK1A overexpression blocked SH-SY5Y cell proliferation in G₁ phase and induced neuronal differentiation.
  • DYRK1A modulated cell cycle protein stability by reducing Cyclin D1 via phosphorylation-induced degradation and stabilizing p27(Kip1) through phosphorylation.
  • Inhibition of DYRK1A kinase activity decreased p27(Kip1) phosphorylation in neurons and brain tissue.

Conclusions:

  • DYRK1A kinase activity plays a critical role in regulating neuronal cell cycle progression and differentiation.
  • Overexpression of DYRK1A may lead to premature neuronal differentiation, contributing to altered brain development observed in Down syndrome.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K